This is a Validated Antibody Database (VAD) review about mouse Icam1, based on 108 published articles (read how Labome selects the articles), using Icam1 antibody in all methods. It is aimed to help Labome visitors find the most suited Icam1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Icam1 synonym: CD54; Icam-1; Ly-47; MALA-2

BioLegend
rat monoclonal (YN1/1.7.4)
  • immunohistochemistry; mouse; 1:100; loading ...
BioLegend Icam1 antibody (Biolegend, 116101) was used in immunohistochemistry on mouse samples at 1:100. elife (2022) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; loading ...; fig 3e
BioLegend Icam1 antibody (Biolegend, 116105) was used in flow cytometry on mouse samples (fig 3e). Adv Sci (Weinh) (2022) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; loading ...
BioLegend Icam1 antibody (Biolegend, 116119) was used in flow cytometry on mouse samples . Front Immunol (2022) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; loading ...
BioLegend Icam1 antibody (Biolegend, 116102) was used in flow cytometry on mouse samples . Cancer Cell (2021) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend Icam1 antibody (BioLegend, 116115) was used in flow cytometry on mouse samples (fig 6a). PLoS Pathog (2021) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; 1:200; fig 3e
BioLegend Icam1 antibody (Biolegend, YN1/1.7.4) was used in flow cytometry on mouse samples at 1:200 (fig 3e). Front Immunol (2021) ncbi
rat monoclonal (YN1/1.7.4)
  • blocking or activating experiments; mouse; fig 2c
BioLegend Icam1 antibody (BioLegend, YN1/1.7.4) was used in blocking or activating experiments on mouse samples (fig 2c). Front Immunol (2020) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; fig 2d
BioLegend Icam1 antibody (BioLegend, YN1/1.7.4) was used in flow cytometry on mouse samples (fig 2d). J Clin Invest (2021) ncbi
rat monoclonal (YN1/1.7.4)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 5b
BioLegend Icam1 antibody (Biolegend, 116101) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 5b). Nat Metab (2019) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; 1:100; loading ...; fig s6a
BioLegend Icam1 antibody (Biolegend, 116122) was used in flow cytometry on mouse samples at 1:100 (fig s6a). Science (2019) ncbi
rat monoclonal (YN1/1.7.4)
  • western blot; mouse; loading ...; fig 7a
BioLegend Icam1 antibody (BioLegend, YN1/1.7.4) was used in western blot on mouse samples (fig 7a). J Exp Med (2019) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; 1:50; loading ...; fig 1a
BioLegend Icam1 antibody (BioLegend, 116107) was used in flow cytometry on mouse samples at 1:50 (fig 1a). Breast Cancer Res (2019) ncbi
rat monoclonal (YN1/1.7.4)
  • immunocytochemistry; mouse; loading ...; fig 4a
BioLegend Icam1 antibody (Biolegend, 116102) was used in immunocytochemistry on mouse samples (fig 4a). Cell Rep (2018) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend Icam1 antibody (Biolegend, YN1/1.7.4) was used in flow cytometry on mouse samples (fig 4d). J Immunol (2018) ncbi
rat monoclonal (YN1/1.7.4)
  • blocking or activating experiments; mouse; loading ...; fig 2e
BioLegend Icam1 antibody (BioLegend, 116101) was used in blocking or activating experiments on mouse samples (fig 2e). Nat Commun (2018) ncbi
rat monoclonal (YN1/1.7.4)
  • immunohistochemistry; human; 1:200; loading ...; fig 1c
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3a
In order to study the involvement of SENP1-mediated GATA2 deSUMOylation in graft arteriosclerosis, BioLegend Icam1 antibody (Biolegend, 116102) was used in immunohistochemistry on human samples at 1:200 (fig 1c) and in immunohistochemistry on mouse samples at 1:200 (fig 3a). Nat Commun (2017) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; fig 7
BioLegend Icam1 antibody (Biolegend, YN1/1.7.4) was used in flow cytometry on mouse samples (fig 7). PLoS ONE (2016) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend Icam1 antibody (BioLegend, YN1/1.7.4) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2016) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; loading ...; fig 5k
In order to study how IL-17 and IFN-gamma control Staphylococcus aureus infection, BioLegend Icam1 antibody (BioLegend, YN1/1.7.4) was used in flow cytometry on mouse samples (fig 5k). Am J Pathol (2016) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; fig 4e
In order to examine the impact of emergency granulopoiesis on T and B cell function, BioLegend Icam1 antibody (Biolegend, YN1/1.7.4) was used in flow cytometry on mouse samples (fig 4e). J Exp Med (2016) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; fig 2
BioLegend Icam1 antibody (Biolegend, YN1/1.7.4) was used in flow cytometry on mouse samples (fig 2). Thyroid (2016) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; loading ...
In order to determine the role of dendritic cell actin regulation in immunological synapse formation, stabilization, and function, BioLegend Icam1 antibody (BioLegend, YN1/1.7.4) was used in flow cytometry on mouse samples . J Leukoc Biol (2016) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; fig 1
In order to determine the promotion of the formation of conjugates between transformed T helper cells and B lymphoma cells by murid gammaherpesvirus latency-associated protein M2, BioLegend Icam1 antibody (BioLegend, YN1/1.7.4) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2015) ncbi
rat monoclonal (YN1/1.7.4)
  • blocking or activating experiments; mouse; loading ...; fig 1h
In order to study the contribution of p53-induced inflammation to heart failure, BioLegend Icam1 antibody (BioLegend, 116102) was used in blocking or activating experiments on mouse samples (fig 1h). J Mol Cell Cardiol (2015) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; 1:50; fig 2a
BioLegend Icam1 antibody (BioLegend, YN1/1.7.4) was used in flow cytometry on mouse samples at 1:50 (fig 2a). Nature (2015) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; 1:200; fig 2
BioLegend Icam1 antibody (Biolegend, 116108) was used in flow cytometry on mouse samples at 1:200 (fig 2). Immun Ageing (2015) ncbi
rat monoclonal (YN1/1.7.4)
  • immunocytochemistry; mouse
In order to evaluate a model of cerebral malaria pathogenesis and its effect on the blood brain barrier, BioLegend Icam1 antibody (Biolegend, YN 1/1.7.4) was used in immunocytochemistry on mouse samples . PLoS Pathog (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (15.2)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 6o
Santa Cruz Biotechnology Icam1 antibody (Santa cruz, sc-107) was used in immunohistochemistry on mouse samples at 1:200 (fig 6o). Ann Clin Transl Neurol (2022) ncbi
mouse monoclonal (G-5)
  • western blot; rat; 1:500; loading ...; fig 9c
Santa Cruz Biotechnology Icam1 antibody (Santa, sc-8439) was used in western blot on rat samples at 1:500 (fig 9c). Invest Ophthalmol Vis Sci (2021) ncbi
mouse monoclonal (2Q710)
  • western blot; mouse; 1:200; loading ...; fig 7f
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz Biotechnology, sc-71292) was used in western blot on mouse samples at 1:200 (fig 7f). Am J Pathol (2021) ncbi
mouse monoclonal (G-5)
  • western blot; mouse; loading ...; fig 3a
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz, sc-8439) was used in western blot on mouse samples (fig 3a). Int J Mol Sci (2021) ncbi
mouse monoclonal (G-5)
  • immunohistochemistry - paraffin section; mouse; 1:800; loading ...; fig 3
  • western blot; mouse; 1:1000; loading ...; fig 4c
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz, sc-8439) was used in immunohistochemistry - paraffin section on mouse samples at 1:800 (fig 3) and in western blot on mouse samples at 1:1000 (fig 4c). Int J Mol Med (2021) ncbi
mouse monoclonal (G-5)
  • immunocytochemistry; human; 1:50; loading ...; fig 2s2d
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz Biotechnology, sc-8439) was used in immunocytochemistry on human samples at 1:50 (fig 2s2d). elife (2020) ncbi
mouse monoclonal (G-5)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s14b
Santa Cruz Biotechnology Icam1 antibody (Santa, SC-8439) was used in immunohistochemistry - paraffin section on mouse samples (fig s14b). Science (2018) ncbi
mouse monoclonal (G-5)
  • western blot; human; 1:400; loading ...; fig 8c
In order to research the role of TRAF3IP2 in endothelin-1 production and inflammation in endothelial cells, Santa Cruz Biotechnology Icam1 antibody (SantaCruz, sc-8439) was used in western blot on human samples at 1:400 (fig 8c). Am J Physiol Heart Circ Physiol (2018) ncbi
mouse monoclonal (15.2)
  • western blot; human; loading ...; fig 5
In order to research the role of the ESCRT membrane budding complex in LINE retrotransposition, Santa Cruz Biotechnology Icam1 antibody (Santa cruz, Sc-107) was used in western blot on human samples (fig 5). PLoS Genet (2017) ncbi
mouse monoclonal (6.5B5)
  • western blot; mouse; loading ...; fig 1d
In order to investigate the role of nuclear factor erythroid 2-related factor in cigarette smoking-induced cerebrobvascular/blood brain barrier impairments, Santa Cruz Biotechnology Icam1 antibody (Santa Cruz, sc-18853) was used in western blot on mouse samples (fig 1d). Redox Biol (2017) ncbi
mouse monoclonal (G-5)
  • western blot; human; 1:1000; loading ...; fig 2d
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz Biotechnology, sc-8439) was used in western blot on human samples at 1:1000 (fig 2d). Oncotarget (2017) ncbi
mouse monoclonal (G-5)
  • immunohistochemistry - paraffin section; rat; 1:325; loading ...; fig 4d
  • western blot; rat; 1:325; loading ...
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz, sc-8439) was used in immunohistochemistry - paraffin section on rat samples at 1:325 (fig 4d) and in western blot on rat samples at 1:325. Front Pharmacol (2016) ncbi
rat monoclonal (5K16)
  • western blot; mouse; loading ...; fig 4a
Santa Cruz Biotechnology Icam1 antibody (SantaCruz, sc-71303) was used in western blot on mouse samples (fig 4a). Mol Med Rep (2016) ncbi
mouse monoclonal (15.2)
  • western blot; human; fig 1
In order to assess the effects of PPARalpha and delta agonists on ICAM-1 expression in primary human endothelial cells, Santa Cruz Biotechnology Icam1 antibody (Santa Cruz, SC-107) was used in western blot on human samples (fig 1). J Inflamm (Lond) (2016) ncbi
mouse monoclonal (15.2)
  • western blot; human; fig 5
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz, sc-107) was used in western blot on human samples (fig 5). Orphanet J Rare Dis (2016) ncbi
mouse monoclonal (G-5)
  • western blot; human; fig 3B
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz, sc-8439) was used in western blot on human samples (fig 3B). PLoS ONE (2016) ncbi
mouse monoclonal (15.2)
  • western blot; human; fig 2
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz, sc-107) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (6.5B5)
  • immunohistochemistry; mouse; 1:100-1:200; fig 5
In order to characterize defects in heart development and embryonic lethality due to cardiac-specific activation of IKK2, Santa Cruz Biotechnology Icam1 antibody (Santa Cruz, sc-18853) was used in immunohistochemistry on mouse samples at 1:100-1:200 (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (15.2)
  • flow cytometry; human; fig 2
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz, sc-107) was used in flow cytometry on human samples (fig 2). Mol Cancer (2015) ncbi
mouse monoclonal (15.2)
  • other; human; loading ...; fig 1
In order to describe mechanisms by which R7020 inhibits intimal hyperplasia, Santa Cruz Biotechnology Icam1 antibody (Santa cruz biotechnology, SC-107) was used in other on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (G-5)
  • immunohistochemistry - paraffin section; human; 4 ug/ml; fig s7
  • western blot; human; 0.3 ug/ml; fig 5a
Santa Cruz Biotechnology Icam1 antibody (Santa cruz, sc-8439) was used in immunohistochemistry - paraffin section on human samples at 4 ug/ml (fig s7) and in western blot on human samples at 0.3 ug/ml (fig 5a). Mol Cancer (2015) ncbi
mouse monoclonal (G-5)
  • western blot; rat; 1:500; loading ...; fig 7c
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz Biotechnology, sc-8439) was used in western blot on rat samples at 1:500 (fig 7c). Mol Med Rep (2015) ncbi
mouse monoclonal (15.2)
  • immunohistochemistry - paraffin section; mouse; fig 1
In order to investigate if and how mTOR regulates YAP, Santa Cruz Biotechnology Icam1 antibody (Santa Cruz Biotechnology, sc-107) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). J Exp Med (2014) ncbi
mouse monoclonal (G-5)
  • western blot; human; fig 1
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz, sc-8439) was used in western blot on human samples (fig 1). Basic Res Cardiol (2014) ncbi
mouse monoclonal (15.2)
  • immunohistochemistry; human; 1:50
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz Biotechnology, sc-107) was used in immunohistochemistry on human samples at 1:50. PLoS ONE (2014) ncbi
mouse monoclonal (G-5)
  • immunohistochemistry - paraffin section; mouse; 1:400
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz, sc-8439) was used in immunohistochemistry - paraffin section on mouse samples at 1:400. J Mol Cell Cardiol (2014) ncbi
mouse monoclonal (6.5B5)
  • western blot; human
Santa Cruz Biotechnology Icam1 antibody (Santa Cruz Biotechnology, sc-18853) was used in western blot on human samples . Free Radic Biol Med (2014) ncbi
Abcam
mouse monoclonal (MEM-111)
  • western blot; human; 1:1000; fig 6e
Abcam Icam1 antibody (Abcam, ab2213) was used in western blot on human samples at 1:1000 (fig 6e). Cell Mol Life Sci (2022) ncbi
mouse monoclonal (MEM-111)
  • western blot; human; loading ...; fig 3c, 3d
Abcam Icam1 antibody (Abcam, ab2213) was used in western blot on human samples (fig 3c, 3d). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (EPR16608)
  • western blot; mouse; loading ...; fig 3c
Abcam Icam1 antibody (Abcam, ab179707) was used in western blot on mouse samples (fig 3c). Front Cell Infect Microbiol (2021) ncbi
mouse monoclonal (1A29)
  • immunohistochemistry; mouse; loading ...; fig 5a
Abcam Icam1 antibody (Abcam, ab 171123) was used in immunohistochemistry on mouse samples (fig 5a). J Endocrinol (2021) ncbi
mouse monoclonal (1A29)
  • western blot; rat; 1:2000; loading ...; fig 3a
Abcam Icam1 antibody (Abcam, ab171123) was used in western blot on rat samples at 1:2000 (fig 3a). Front Pharmacol (2020) ncbi
rat monoclonal (YN1/1.7.4)
  • western blot; mouse; loading ...; fig 4c
Abcam Icam1 antibody (Abcam, ab25375) was used in western blot on mouse samples (fig 4c). Am J Physiol Cell Physiol (2020) ncbi
rat monoclonal (YN1/1.7.4)
  • immunohistochemistry; mouse; loading ...
Abcam Icam1 antibody (Abcam, YN1/1.7.4) was used in immunohistochemistry on mouse samples . Nat Commun (2020) ncbi
domestic rabbit monoclonal (EPR16608)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2a
Abcam Icam1 antibody (Abcam, ab179707) was used in immunohistochemistry - paraffin section on mouse samples (fig 2a). J Clin Med (2020) ncbi
rat monoclonal (YN1/1.7.4)
  • western blot; rat; 1:1000; loading ...; fig 3b
Abcam Icam1 antibody (Abcam, ab119871) was used in western blot on rat samples at 1:1000 (fig 3b). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (EPR16608)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 2c
  • western blot; mouse; 1:750; loading ...; fig 3d
Abcam Icam1 antibody (Abcam, ab179707) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2c) and in western blot on mouse samples at 1:750 (fig 3d). Nat Commun (2019) ncbi
mouse monoclonal (1A29)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6a
Abcam Icam1 antibody (Abcam, ab171123) was used in immunohistochemistry - paraffin section on mouse samples (fig 6a). J Clin Invest (2019) ncbi
rat monoclonal (YN1/1.7.4)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 3c
Abcam Icam1 antibody (Abcam, ab119871) was used in immunohistochemistry - frozen section on mouse samples (fig 3c). Nat Commun (2018) ncbi
rat monoclonal (YN1/1.7.4)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3a
Abcam Icam1 antibody (Abcam, ab119871) was used in immunohistochemistry on mouse samples at 1:200 (fig 3a). PLoS ONE (2018) ncbi
rat monoclonal (YN1/1.7.4)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4a
Abcam Icam1 antibody (Abcam, ab119871) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4a). Nat Commun (2018) ncbi
mouse monoclonal (1A29)
  • immunohistochemistry - frozen section; rat; loading ...; fig 1q
Abcam Icam1 antibody (Abcam, ab171123) was used in immunohistochemistry - frozen section on rat samples (fig 1q). Brain Behav Immun (2018) ncbi
mouse monoclonal (MEM-111)
  • western blot; rat; fig 7
Abcam Icam1 antibody (Abcam, ab2213) was used in western blot on rat samples (fig 7). Acta Pharmacol Sin (2016) ncbi
mouse monoclonal (MEM-111)
  • immunohistochemistry; mouse; 1:200; fig 1b
  • immunohistochemistry - paraffin section; human; 1:20; fig 1c
In order to study how mitigation of Alzheimer's disease pathology occurs by breaking immune tolerance by targeting Foxp3(+) regulatory T cells, Abcam Icam1 antibody (Abcam, ab2213) was used in immunohistochemistry on mouse samples at 1:200 (fig 1b) and in immunohistochemistry - paraffin section on human samples at 1:20 (fig 1c). Nat Commun (2015) ncbi
rat monoclonal (YN1/1.7.4)
  • immunohistochemistry; mouse; 1:200; fig 6
Abcam Icam1 antibody (Abcam, ab119871) was used in immunohistochemistry on mouse samples at 1:200 (fig 6). J Cell Mol Med (2015) ncbi
mouse monoclonal (MEM-111)
  • western blot; rat; fig 6
Abcam Icam1 antibody (Abcam, ab2213) was used in western blot on rat samples (fig 6). Free Radic Biol Med (2015) ncbi
mouse monoclonal (MEM-111)
  • immunocytochemistry; human; 1:100; tbl 1
Abcam Icam1 antibody (Abcam, ab2213) was used in immunocytochemistry on human samples at 1:100 (tbl 1). Acta Biomater (2015) ncbi
mouse monoclonal (MEM-111)
  • immunohistochemistry - paraffin section; rat; 1:100
Abcam Icam1 antibody (Abcam, ab2213) was used in immunohistochemistry - paraffin section on rat samples at 1:100. Mol Pharm (2014) ncbi
mouse monoclonal (MEM-111)
  • western blot; rat; 1:2000
Abcam Icam1 antibody (Abcam, ab2213) was used in western blot on rat samples at 1:2000. Evid Based Complement Alternat Med (2013) ncbi
rat monoclonal (YN1/1.7.4)
  • immunohistochemistry; mouse; 1:200
Abcam Icam1 antibody (Abcam, ab119871) was used in immunohistochemistry on mouse samples at 1:200. Nat Med (2013) ncbi
Invitrogen
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; 1:200; loading ...; fig 2d, 3a
Invitrogen Icam1 antibody (eBioscience, 11-0541-82) was used in flow cytometry on mouse samples at 1:200 (fig 2d, 3a). Development (2022) ncbi
hamsters monoclonal (3E2B)
  • flow cytometry; mouse; loading ...; fig s8a
Invitrogen Icam1 antibody (Invitrogen, MA5405) was used in flow cytometry on mouse samples (fig s8a). Front Immunol (2021) ncbi
rat monoclonal (YN1/1.7.4)
  • immunohistochemistry; mouse; loading ...; fig 1g
Invitrogen Icam1 antibody (eBioscience, 14-0541) was used in immunohistochemistry on mouse samples (fig 1g). J Clin Invest (2019) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; loading ...; fig 1f
Invitrogen Icam1 antibody (ThermoFisher Scientific, 13-0541) was used in flow cytometry on mouse samples (fig 1f). Cell Stem Cell (2017) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; loading ...; fig 2b
In order to examine the role of herpes virus entry mediator in corneal disease during viral infection, Invitrogen Icam1 antibody (eBiosciences, YN1/1.7.4) was used in flow cytometry on mouse samples (fig 2b). Invest Ophthalmol Vis Sci (2017) ncbi
rat monoclonal (eBioKAT-1 (KAT-1, KAT1))
  • immunohistochemistry; mouse; loading ...; fig 1b
Invitrogen Icam1 antibody (eBiosciences, KAT-1) was used in immunohistochemistry on mouse samples (fig 1b). Diabetes (2017) ncbi
rat monoclonal (YN1/1.7.4)
  • blocking or activating experiments; mouse; fig 8
Invitrogen Icam1 antibody (eBioscience, 160541) was used in blocking or activating experiments on mouse samples (fig 8). Nat Commun (2016) ncbi
rat monoclonal (eBioKAT-1 (KAT-1, KAT1))
  • flow cytometry; mouse; loading ...; fig st1
In order to study how bone marrow endothelial cells regulate bone marrow stem cell maintenance and leukocyte trafficking, Invitrogen Icam1 antibody (eBioscience, eBioKAT-1) was used in flow cytometry on mouse samples (fig st1). Nature (2016) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; 1:100; fig 5
In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen Icam1 antibody (eBioscience, YN1/1.7.4) was used in flow cytometry on mouse samples at 1:100 (fig 5). Nat Commun (2016) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse; fig 7
In order to study how DNAM-1 controls NK cell-mediated cytotoxicity and cytokine production, Invitrogen Icam1 antibody (eBioscience, YN1/1.7.4) was used in flow cytometry on mouse samples (fig 7). J Exp Med (2015) ncbi
rat monoclonal (eBioKAT-1 (KAT-1, KAT1))
  • flow cytometry; mouse; 1:500
Invitrogen Icam1 antibody (eBioscience, KAT-1) was used in flow cytometry on mouse samples at 1:500. Cell Res (2015) ncbi
domestic rabbit recombinant (9H21L19)
  • western blot; human; fig 5
In order to characterize the proteomic content of lymphoma cell-derived exosomes, Invitrogen Icam1 antibody (Thermo, 9H21L19) was used in western blot on human samples (fig 5). Eur J Med Res (2015) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse
In order to evaluate a model of cerebral malaria pathogenesis and its effect on the blood brain barrier, Invitrogen Icam1 antibody (eBioscience, YN1/1.7.4) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse
Invitrogen Icam1 antibody (eBioscience, 11-0541-82) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (YN1/1.7.4)
  • immunocytochemistry; mouse; tbl 1
In order to study the effect of innate lymphoid cells on B cells, Invitrogen Icam1 antibody (eBioscience, YN1/1.7.4) was used in immunocytochemistry on mouse samples (tbl 1). Nat Immunol (2014) ncbi
rat monoclonal (eBioKAT-1 (KAT-1, KAT1))
  • immunohistochemistry; human; fig 6
In order to identify intercellular adhesion molecule-1 as a new coreceptor for c-Met, Invitrogen Icam1 antibody (eBioscience, 16-0542) was used in immunohistochemistry on human samples (fig 6). Mol Biol Cell (2011) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; mouse
In order to investigate crosstalk between that osteoclasts and T cells, Invitrogen Icam1 antibody (eBioscience, YN1/1.7.4) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (YN1/1.7.4)
  • immunohistochemistry; mouse; 1:100
Invitrogen Icam1 antibody (eBioscience, 14-0541-81) was used in immunohistochemistry on mouse samples at 1:100. Neuroscience (2007) ncbi
rat monoclonal (YN1/1.7.4)
  • flow cytometry; human; fig 6
In order to study conformational changes of the leukocyte integrin alphaLbeta2, Invitrogen Icam1 antibody (eBioscience, YN1/1.7.4) was used in flow cytometry on human samples (fig 6). J Biol Chem (2005) ncbi
mouse monoclonal (1A29)
  • immunohistochemistry; rat; 1:50; fig 3
  • western blot; rat; 1:50; fig 5
In order to elucidate the role of adhesion molecules in the pathogenesis of experimental allergic myositis, Invitrogen Icam1 antibody (Caltag, 1A29) was used in immunohistochemistry on rat samples at 1:50 (fig 3) and in western blot on rat samples at 1:50 (fig 5). Muscle Nerve (2002) ncbi
R&D Systems
domestic goat polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5f
R&D Systems Icam1 antibody (R&D systems, AF796) was used in immunohistochemistry - paraffin section on mouse samples (fig 5f). Cell Death Dis (2022) ncbi
domestic goat polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig s7a
R&D Systems Icam1 antibody (R&D, AF796) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s7a). Theranostics (2021) ncbi
BD Biosciences
hamsters monoclonal (3E2)
  • flow cytometry; mouse; 1:100; loading ...; fig 1e
BD Biosciences Icam1 antibody (BD Biosciences, 561605) was used in flow cytometry on mouse samples at 1:100 (fig 1e). Nat Commun (2021) ncbi
hamsters monoclonal (3E2)
  • blocking or activating experiments; mouse; fig 5c
BD Biosciences Icam1 antibody (BD Biosciences, 550287) was used in blocking or activating experiments on mouse samples (fig 5c). elife (2020) ncbi
hamsters monoclonal (3E2)
  • flow cytometry; mouse; loading ...; fig s14c
BD Biosciences Icam1 antibody (BD Biosciences, 3E2) was used in flow cytometry on mouse samples (fig s14c). Science (2018) ncbi
hamsters monoclonal (3E2)
  • flow cytometry; mouse; loading ...; fig 1b
BD Biosciences Icam1 antibody (BD Pharmingen, 561605) was used in flow cytometry on mouse samples (fig 1b). Exp Ther Med (2017) ncbi
hamsters monoclonal (3E2)
  • flow cytometry; mouse; fig s2b
In order to determine the origin of pericytes in adult angiogenesis, BD Biosciences Icam1 antibody (BD Biosciences, 3E2) was used in flow cytometry on mouse samples (fig s2b). Cell Res (2016) ncbi
hamsters monoclonal (3E2)
  • immunohistochemistry - frozen section; mouse; tbl 1
BD Biosciences Icam1 antibody (BD-Pharmingen, 553251) was used in immunohistochemistry - frozen section on mouse samples (tbl 1). PLoS ONE (2016) ncbi
hamsters monoclonal (3E2)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BD Biosciences Icam1 antibody (BD, 3E2) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
hamsters monoclonal (3E2)
  • flow cytometry; mouse; 1:50; fig 2a
BD Biosciences Icam1 antibody (BD, 3E2) was used in flow cytometry on mouse samples at 1:50 (fig 2a). Nature (2015) ncbi
hamsters monoclonal (3E2)
  • flow cytometry; mouse; loading ...; fig 1
In order to use flow cytometry to determine the profile of markers associated with ventilator-induced lung injury, BD Biosciences Icam1 antibody (BD Biosciences, 3E2) was used in flow cytometry on mouse samples (fig 1). Am J Physiol Lung Cell Mol Physiol (2015) ncbi
hamsters monoclonal (3E2)
  • flow cytometry; mouse
In order to elucidate the factors that mediate radiation-induced endothelial dysfunction, BD Biosciences Icam1 antibody (BD, 3E2) was used in flow cytometry on mouse samples . J Proteome Res (2015) ncbi
hamsters monoclonal (3E2)
  • flow cytometry; mouse
BD Biosciences Icam1 antibody (BD Biosciences, 3E2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
hamsters monoclonal (3E2)
  • flow cytometry; mouse
In order to study the expression of extracellular matrix proteins in diabetic nephropathy, BD Biosciences Icam1 antibody (BD, 553250) was used in flow cytometry on mouse samples . Am J Physiol Renal Physiol (2013) ncbi
Articles Reviewed
  1. Tran N, Ferreira L, Alvarez Moya B, Buttiglione V, Ferrini B, Zordan P, et al. Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier. elife. 2022;11: pubmed publisher
  2. Hamdi L, Nabat H, Goldberg Y, Fainstein N, Segal S, Mediouni E, et al. Exercise training alters autoimmune cell invasion into the brain in autoimmune encephalomyelitis. Ann Clin Transl Neurol. 2022;9:1792-1806 pubmed publisher
  3. Wakao S, Oguma Y, Kushida Y, Kuroda Y, Tatsumi K, Dezawa M. Phagocytosing differentiated cell-fragments is a novel mechanism for controlling somatic stem cell differentiation within a short time frame. Cell Mol Life Sci. 2022;79:542 pubmed publisher
  4. Lin J, Lv J, Yu S, Chen Y, Wang H, Chen J. Transcript Engineered Extracellular Vesicles Alleviate Alloreactive Dynamics in Renal Transplantation. Adv Sci (Weinh). 2022;9:e2202633 pubmed publisher
  5. Regev O, Kizner M, Roncato F, Dadiani M, Saini M, Castro Giner F, et al. ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells. Front Immunol. 2022;13:849701 pubmed publisher
  6. Jin Y, Liu Y, Xu L, Xu J, Xiong Y, Peng Y, et al. Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis. Cell Death Dis. 2022;13:512 pubmed publisher
  7. Meléndez E, Chondronasiou D, Mosteiro L, Mart xed nez de Villarreal J, Fern xe1 ndez Alfara M, Lynch C, et al. Natural killer cells act as an extrinsic barrier for in vivo reprogramming. Development. 2022;149: pubmed publisher
  8. Qin Z, Liu F, Blair R, Wang C, Yang H, Mudd J, et al. Endothelial cell infection and dysfunction, immune activation in severe COVID-19. Theranostics. 2021;11:8076-8091 pubmed publisher
  9. Hutton C, Heider F, Blanco Gómez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;: pubmed publisher
  10. Abu El Asrar A, Nawaz M, Ahmad A, Siddiquei M, Allegaert E, Gikandi P, et al. CD146/Soluble CD146 Pathway Is a Novel Biomarker of Angiogenesis and Inflammation in Proliferative Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2021;62:32 pubmed publisher
  11. Saadane A, Du Y, Thoreson W, Miyagi M, Lessieur E, Kiser J, et al. Photoreceptor Cell Calcium Dysregulation and Calpain Activation Promote Pathogenic Photoreceptor Oxidative Stress and Inflammation in Prodromal Diabetic Retinopathy. Am J Pathol. 2021;191:1805-1821 pubmed publisher
  12. Li C, Li J, Loreno E, Miriyala S, Panchatcharam M, Lu X, et al. Chronic Low-Dose Alcohol Consumption Attenuates Post-Ischemic Inflammation via PPARγ in Mice. Int J Mol Sci. 2021;22: pubmed publisher
  13. Yao J, Yang Z, Yang J, Wang Z, Zhang Z. Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis. Aging (Albany NY). 2021;13:13726-13738 pubmed publisher
  14. Lin T, Quellier D, Lamb J, Voisin T, Baral P, Bock F, et al. Pseudomonas aeruginosa-induced nociceptor activation increases susceptibility to infection. PLoS Pathog. 2021;17:e1009557 pubmed publisher
  15. Zhang S, Li L, Xie D, Reddy S, Sleasman J, Ma L, et al. Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1. Front Immunol. 2021;12:620437 pubmed publisher
  16. Anania J, Westin A, Adler J, Heyman B. A Novel Image Analysis Approach Reveals a Role for Complement Receptors 1 and 2 in Follicular Dendritic Cell Organization in Germinal Centers. Front Immunol. 2021;12:655753 pubmed publisher
  17. Nishina T, Deguchi Y, Ohshima D, Takeda W, Ohtsuka M, Shichino S, et al. Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer. Nat Commun. 2021;12:2281 pubmed publisher
  18. Sun Y, Wu D, Zeng W, Chen Y, Guo M, Lu B, et al. The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis. Front Cell Infect Microbiol. 2021;11:618265 pubmed publisher
  19. Uhl B, Braun C, Dominik J, Luft J, Canis M, Reichel C. A Novel Experimental Approach for In Vivo Analyses of the Salivary Gland Microvasculature. Front Immunol. 2020;11:604470 pubmed publisher
  20. Zhang R, Guo N, Yan G, Wang Q, Gao T, Zhang B, et al. Ginkgolide C attenuates lipopolysaccharide‑induced acute lung injury by inhibiting inflammation via regulating the CD40/NF‑κB signaling pathway. Int J Mol Med. 2021;47: pubmed publisher
  21. Li B, Yin J, Chang J, Zhang J, Wang Y, Huang H, et al. Apelin/APJ relieve diabetic cardiomyopathy by reducing microvascular dysfunction. J Endocrinol. 2021;249:1-18 pubmed publisher
  22. Wang T, Liu C, Pan L, Liu Z, Li C, Lin J, et al. Inhibition of p38 MAPK Mitigates Lung Ischemia Reperfusion Injury by Reducing Blood-Air Barrier Hyperpermeability. Front Pharmacol. 2020;11:569251 pubmed publisher
  23. Pariser D, Hilt Z, Ture S, Blick Nitko S, Looney M, Cleary S, et al. Lung megakaryocytes are immune modulatory cells. J Clin Invest. 2021;131: pubmed publisher
  24. Cabañero D, Ramírez López A, Drews E, Schmöle A, Otte D, Wawrzczak Bargiela A, et al. Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain. elife. 2020;9: pubmed publisher
  25. Maqbool A, Watt N, Haywood N, Viswambharan H, Skromna A, Makava N, et al. Divergent effects of genetic and pharmacological inhibition of Nox2 NADPH oxidase on insulin resistance-related vascular damage. Am J Physiol Cell Physiol. 2020;319:C64-C74 pubmed publisher
  26. Barruet E, Garcia S, Striedinger K, Wu J, Lee S, Byrnes L, et al. Functionally heterogeneous human satellite cells identified by single cell RNA sequencing. elife. 2020;9: pubmed publisher
  27. Choi S, Bae H, Jeong S, Park I, Cho H, Hong S, et al. YAP/TAZ direct commitment and maturation of lymph node fibroblastic reticular cells. Nat Commun. 2020;11:519 pubmed publisher
  28. Lin C, Lin W, Cho R, Yang C, Yeh Y, Hsiao L, et al. Induction of HO-1 by Mevastatin Mediated via a Nox/ROS-Dependent c-Src/PDGFRα/PI3K/Akt/Nrf2/ARE Cascade Suppresses TNF-α-Induced Lung Inflammation. J Clin Med. 2020;9: pubmed publisher
  29. Welsh J, Hoofnagle M, Bamezai S, Oxendine M, Lim L, Hall J, et al. Hemodynamic regulation of perivalvular endothelial gene expression prevents deep venous thrombosis. J Clin Invest. 2019;129:5489-5500 pubmed publisher
  30. Grüneboom A, Hawwari I, Weidner D, Culemann S, Müller S, Henneberg S, et al. A network of trans-cortical capillaries as mainstay for blood circulation in long bones. Nat Metab. 2019;1:236-250 pubmed publisher
  31. Liu Y, Liu L, Jia Y, Sun Y, Ma F. Role of microRNA-15a-5p in the atherosclerotic inflammatory response and arterial injury improvement of diabetic by targeting FASN. Biosci Rep. 2019;: pubmed publisher
  32. Bertrand L, Méroth F, Tournebize M, Leda A, Sun E, Toborek M. Targeting the HIV-infected brain to improve ischemic stroke outcome. Nat Commun. 2019;10:2009 pubmed publisher
  33. MERRICK D, Sakers A, Irgebay Z, Okada C, Calvert C, Morley M, et al. Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science. 2019;364: pubmed publisher
  34. Mentrup T, Theodorou K, Cabrera Cabrera F, Helbig A, Happ K, Gijbels M, et al. Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis. J Exp Med. 2019;: pubmed publisher
  35. Chiche A, Di Cicco A, Sesma Sanz L, Bresson L, de la Grange P, Glukhova M, et al. p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signaling. Breast Cancer Res. 2019;21:13 pubmed publisher
  36. Hu Y, Guo F, Xu Y, Li P, Lu Z, McVey D, et al. Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXN. J Clin Invest. 2019;129:1115-1128 pubmed publisher
  37. Ruscetti M, Leibold J, Bott M, Fennell M, Kulick A, Salgado N, et al. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 2018;362:1416-1422 pubmed publisher
  38. Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25:3059-3073.e10 pubmed publisher
  39. Lund H, Pieber M, Parsa R, Han J, Grommisch D, Ewing E, et al. Competitive repopulation of an empty microglial niche yields functionally distinct subsets of microglia-like cells. Nat Commun. 2018;9:4845 pubmed publisher
  40. Finsterwalder R, Ganesan M, Leb H, Habertheuer A, Basílio J, Lang I, et al. Hypoxia/reperfusion predisposes to atherosclerosis. PLoS ONE. 2018;13:e0205067 pubmed publisher
  41. García Nores G, Ly C, Cuzzone D, Kataru R, Hespe G, Torrisi J, et al. CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema. Nat Commun. 2018;9:1970 pubmed publisher
  42. Thomson C, van de Pavert S, Stakenborg M, Labeeuw E, Matteoli G, Mowat A, et al. Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses Endothelial Cell Regulators. J Immunol. 2018;201:215-229 pubmed publisher
  43. Beazley Long N, Moss C, Ashby W, Bestall S, Almahasneh F, Durrant A, et al. VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritis. Brain Behav Immun. 2018;74:49-67 pubmed publisher
  44. Wolf D, Anto Michel N, Blankenbach H, Wiedemann A, Buscher K, Hohmann J, et al. A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense. Nat Commun. 2018;9:525 pubmed publisher
  45. Ruetz T, Pfisterer U, Di Stefano B, Ashmore J, Beniazza M, Tian T, et al. Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming. Cell Stem Cell. 2017;21:791-805.e9 pubmed publisher
  46. Padilla J, Carpenter A, Das N, Kandikattu H, López Ongil S, Martinez Lemus L, et al. TRAF3IP2 mediates high glucose-induced endothelin-1 production as well as endothelin-1-induced inflammation in endothelial cells. Am J Physiol Heart Circ Physiol. 2018;314:H52-H64 pubmed publisher
  47. Horn A, Celic I, Dong C, Martirosyan I, Han J. A conserved role for the ESCRT membrane budding complex in LINE retrotransposition. PLoS Genet. 2017;13:e1006837 pubmed publisher
  48. Qiu C, Wang Y, Zhao H, Qin L, Shi Y, Zhu X, et al. The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis. Nat Commun. 2017;8:15426 pubmed publisher
  49. Li Q, Xia S, Fang H, Pan J, Jia Y, Deng G. VEGF treatment promotes bone marrow-derived CXCR4+ mesenchymal stromal stem cell differentiation into vessel endothelial cells. Exp Ther Med. 2017;13:449-454 pubmed publisher
  50. Prasad S, Sajja R, Kaisar M, Park J, Villalba H, Liles T, et al. Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity. Redox Biol. 2017;12:58-69 pubmed publisher
  51. Edwards R, Kopp S, Ifergan I, Shui J, Kronenberg M, Miller S, et al. Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy. Invest Ophthalmol Vis Sci. 2017;58:282-291 pubmed publisher
  52. Bonan S, Albrengues J, Grasset E, Kuzet S, Nottet N, Bourget I, et al. Membrane-bound ICAM-1 contributes to the onset of proinvasive tumor stroma by controlling acto-myosin contractility in carcinoma-associated fibroblasts. Oncotarget. 2017;8:1304-1320 pubmed publisher
  53. Di Paola R, Fusco R, Gugliandolo E, Crupi R, Evangelista M, Granese R, et al. Co-micronized Palmitoylethanolamide/Polydatin Treatment Causes Endometriotic Lesion Regression in a Rodent Model of Surgically Induced Endometriosis. Front Pharmacol. 2016;7:382 pubmed
  54. Ushiki T, Huntington N, Glaser S, Kiu H, Georgiou A, Zhang J, et al. Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells. PLoS ONE. 2016;11:e0162111 pubmed publisher
  55. Han H, Chen Y, Zhu J, Ni J, Sun J, Zhang R. Atorvastatin attenuates p?cresyl sulfate?induced atherogenesis and plaque instability in ApoE knockout mice. Mol Med Rep. 2016;14:3122-8 pubmed publisher
  56. Naidenow J, Hrgovic I, Doll M, Hailemariam Jahn T, Lang V, Kleemann J, et al. Peroxisome proliferator-activated receptor (PPAR) ? and ? activators induce ICAM-1 expression in quiescent non stimulated endothelial cells. J Inflamm (Lond). 2016;13:27 pubmed publisher
  57. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  58. Portillo J, Lopez Corcino Y, Miao Y, Tang J, Sheibani N, Kern T, et al. CD40 in Retinal Müller Cells Induces P2X7-Dependent Cytokine Expression in Macrophages/Microglia in Diabetic Mice and Development of Early Experimental Diabetic Retinopathy. Diabetes. 2017;66:483-493 pubmed publisher
  59. Barin J, Talor M, Schaub J, Diny N, Hou X, Hoyer M, et al. Collaborative Interferon-? and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol. 2016;186:2337-52 pubmed publisher
  60. Parsa R, Lund H, Georgoudaki A, Zhang X, Ortlieb Guerreiro Cacais A, Grommisch D, et al. BAFF-secreting neutrophils drive plasma cell responses during emergency granulopoiesis. J Exp Med. 2016;213:1537-53 pubmed publisher
  61. Yu Q, Song W, Wang D, Zeng Y. Identification of blood vascular endothelial stem cells by the expression of protein C receptor. Cell Res. 2016;26:1079-1098 pubmed publisher
  62. Sabry S, Vuillaumier Barrot S, Mintet E, Fasseu M, Valayannopoulos V, Heron D, et al. A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity. Orphanet J Rare Dis. 2016;11:84 pubmed publisher
  63. Brinkman C, Iwami D, Hritzo M, Xiong Y, Ahmad S, Simon T, et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat Commun. 2016;7:12021 pubmed publisher
  64. PACKARD A, Lin B, Schwob J. Sox2 and Pax6 Play Counteracting Roles in Regulating Neurogenesis within the Murine Olfactory Epithelium. PLoS ONE. 2016;11:e0155167 pubmed publisher
  65. Kwon O, Kim K, Lee E, Kim M, Choi S, Li H, et al. Induction of MiR-21 by Stereotactic Body Radiotherapy Contributes to the Pulmonary Fibrotic Response. PLoS ONE. 2016;11:e0154942 pubmed publisher
  66. Itkin T, Gur Cohen S, Spencer J, Schajnovitz A, Ramasamy S, Kusumbe A, et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 2016;532:323-8 pubmed publisher
  67. Zhang Y, Ma X, Guo C, Wang M, Kou N, Qu H, et al. Pretreatment with a combination of ligustrazine and berberine improves cardiac function in rats with coronary microembolization. Acta Pharmacol Sin. 2016;37:463-72 pubmed publisher
  68. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  69. Gawade S, Mayer C, Hafen K, Barthlott T, Krenger W, Szinnai G. Cell Growth Dynamics in Embryonic and Adult Mouse Thyroid Revealed by a Novel Approach to Detect Thyroid Gland Subpopulations. Thyroid. 2016;26:591-9 pubmed publisher
  70. Malinova D, Fritzsche M, Nowosad C, Armer H, Munro P, Blundell M, et al. WASp-dependent actin cytoskeleton stability at the dendritic cell immunological synapse is required for extensive, functional T cell contacts. J Leukoc Biol. 2016;99:699-710 pubmed publisher
  71. Zhang Z, Wu N, Lu Y, Davidson D, Colonna M, Veillette A. DNAM-1 controls NK cell activation via an ITT-like motif. J Exp Med. 2015;212:2165-82 pubmed publisher
  72. Fontinha D, Lopes F, Marques S, Alenquer M, Simas J. Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells. PLoS ONE. 2015;10:e0142540 pubmed publisher
  73. Amigo Jiménez I, Bailón E, Aguilera Montilla N, Terol M, García Marco J, García Pardo A. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways. Oncotarget. 2015;6:44832-48 pubmed publisher
  74. Kraut B, Maier H, Kókai E, Fiedler K, Boettger T, Illing A, et al. Cardiac-Specific Activation of IKK2 Leads to Defects in Heart Development and Embryonic Lethality. PLoS ONE. 2015;10:e0141591 pubmed publisher
  75. Baruch K, Rosenzweig N, Kertser A, Deczkowska A, Sharif A, Spinrad A, et al. Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology. Nat Commun. 2015;6:7967 pubmed publisher
  76. Conigliaro A, Costa V, Lo Dico A, Saieva L, Buccheri S, Dieli F, et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol Cancer. 2015;14:155 pubmed publisher
  77. McCormick S, He Q, Stern J, Khodarev N, Weichselbaum R, Skelly C. Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia. PLoS ONE. 2015;10:e0130264 pubmed publisher
  78. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  79. Yoshida Y, Shimizu I, Katsuumi G, Jiao S, Suda M, Hayashi Y, et al. p53-Induced inflammation exacerbates cardiac dysfunction during pressure overload. J Mol Cell Cardiol. 2015;85:183-98 pubmed publisher
  80. Wang H, Hong L, Huang J, Jiang Q, Tao R, Tan C, et al. P2RX7 sensitizes Mac-1/ICAM-1-dependent leukocyte-endothelial adhesion and promotes neurovascular injury during septic encephalopathy. Cell Res. 2015;25:674-90 pubmed publisher
  81. Koizume S, Ito S, Nakamura Y, Yoshihara M, Furuya M, Yamada R, et al. Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer. Mol Cancer. 2015;14:77 pubmed publisher
  82. Lujan E, Zunder E, Ng Y, Goronzy I, Nolan G, Wernig M. Early reprogramming regulators identified by prospective isolation and mass cytometry. Nature. 2015;521:352-6 pubmed publisher
  83. Luo C, Yuan D, Zhao W, Chen H, Luo G, Su G, et al. Sevoflurane ameliorates intestinal ischemia-reperfusion-induced lung injury by inhibiting the synergistic action between mast cell activation and oxidative stress. Mol Med Rep. 2015;12:1082-90 pubmed publisher
  84. Elahy M, Jackaman C, Mamo J, Lam V, Dhaliwal S, Giles C, et al. Blood-brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment. Immun Ageing. 2015;12:2 pubmed publisher
  85. Woods S, Waite A, O Dea K, Halford P, Takata M, Wilson M. Kinetic profiling of in vivo lung cellular inflammatory responses to mechanical ventilation. Am J Physiol Lung Cell Mol Physiol. 2015;308:L912-21 pubmed publisher
  86. Sun H, Zhang X, Zhao L, Zhen X, Huang S, Wang S, et al. Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor. J Cell Mol Med. 2015;19:836-49 pubmed publisher
  87. Irwin D, Baek J, Hassell K, Nuss R, Eigenberger P, Lisk C, et al. Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration. Free Radic Biol Med. 2015;82:50-62 pubmed publisher
  88. Yao Y, Wei W, Sun J, Chen L, Deng X, Ma L, et al. Proteomic analysis of exosomes derived from human lymphoma cells. Eur J Med Res. 2015;20:8 pubmed publisher
  89. Azimzadeh O, Sievert W, Sarioglu H, Merl Pham J, Yentrapalli R, Bakshi M, et al. Integrative proteomics and targeted transcriptomics analyses in cardiac endothelial cells unravel mechanisms of long-term radiation-induced vascular dysfunction. J Proteome Res. 2015;14:1203-19 pubmed publisher
  90. Nacer A, Movila A, Sohet F, Girgis N, Gundra U, Loke P, et al. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier. PLoS Pathog. 2014;10:e1004528 pubmed publisher
  91. Johnstone S, Liley M, Dalby M, Barnett S. Comparison of human olfactory and skeletal MSCs using osteogenic nanotopography to demonstrate bone-specific bioactivity of the surfaces. Acta Biomater. 2015;13:266-76 pubmed publisher
  92. Liang N, Zhang C, Dill P, Panasyuk G, Pion D, Koka V, et al. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med. 2014;211:2249-63 pubmed publisher
  93. Tassi I, Claudio E, Wang H, Tang W, Ha H, Saret S, et al. The NF-κB regulator Bcl-3 governs dendritic cell antigen presentation functions in adaptive immunity. J Immunol. 2014;193:4303-11 pubmed publisher
  94. Fork C, Hitzel J, Nichols B, Tikkanen R, Brandes R. Flotillin-1 facilitates toll-like receptor 3 signaling in human endothelial cells. Basic Res Cardiol. 2014;109:439 pubmed publisher
  95. Wang X, Xiong M, Zeng Y, Sun X, Gong T, Zhang Z. Mechanistic studies of a novel mycophenolic acid-glucosamine conjugate that attenuates renal ischemia/reperfusion injury in rat. Mol Pharm. 2014;11:3503-14 pubmed publisher
  96. Larsen J, Dall M, Antvorskov J, Weile C, Engkilde K, Josefsen K, et al. Dietary gluten increases natural killer cell cytotoxicity and cytokine secretion. Eur J Immunol. 2014;44:3056-67 pubmed publisher
  97. Toutounchian J, Steinle J, Makena P, Waters C, Wilson M, Haik B, et al. Modulation of radiation injury response in retinal endothelial cells by quinic acid derivative KZ-41 involves p38 MAPK. PLoS ONE. 2014;9:e100210 pubmed publisher
  98. Chen R, Zhang F, Song L, Shu Y, Lin Y, Dong L, et al. Transcriptome profiling reveals that the SM22?-regulated molecular pathways contribute to vascular pathology. J Mol Cell Cardiol. 2014;72:263-72 pubmed publisher
  99. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  100. Valente A, Irimpen A, Siebenlist U, Chandrasekar B. OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators. Free Radic Biol Med. 2014;70:117-28 pubmed publisher
  101. Duan H, Huang J, Li W, Tang M. Protective effects of fufang xueshuantong on diabetic retinopathy in rats. Evid Based Complement Alternat Med. 2013;2013:408268 pubmed publisher
  102. Bittner S, Ruck T, Schuhmann M, Herrmann A, Moha Ou Maati H, Bobak N, et al. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161-5 pubmed publisher
  103. Grutzmacher C, Park S, Zhao Y, Morrison M, Sheibani N, Sorenson C. Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with a short duration of diabetes. Am J Physiol Renal Physiol. 2013;304:F19-30 pubmed publisher
  104. Olaku V, Matzke A, Mitchell C, Hasenauer S, Sakkaravarthi A, Pace G, et al. c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 null mice. Mol Biol Cell. 2011;22:2777-86 pubmed publisher
  105. Kiesel J, Buchwald Z, Aurora R. Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. J Immunol. 2009;182:5477-87 pubmed publisher
  106. Dissing Olesen L, Ladeby R, Nielsen H, Toft Hansen H, Dalmau I, Finsen B. Axonal lesion-induced microglial proliferation and microglial cluster formation in the mouse. Neuroscience. 2007;149:112-22 pubmed
  107. Zhang F, Marcus W, Goyal N, Selvaraj P, Springer T, Zhu C. Two-dimensional kinetics regulation of alphaLbeta2-ICAM-1 interaction by conformational changes of the alphaL-inserted domain. J Biol Chem. 2005;280:42207-18 pubmed
  108. Ito T, Kumamoto T, Horinouchi H, Yukishige K, Sugihara R, Fujimoto S, et al. Adhesion molecule expression in experimental myositis. Muscle Nerve. 2002;25:409-18 pubmed